Target intelligence / Profile preview

Alpha-1,4-glycosidic bond

Molecular classification
Carbohydrate, Polysaccharide, Chemical bond, Other
01

Overview

Alpha-1,4-glycosidic bonds are the primary chemical linkages that connect glucose monomers in dietary starches, including amylose and amylopectin [PubChem]. These bonds serve as a critical energy reservoir in plants and are a major source of dietary calories for humans [NIH]. During digestion, these linkages are hydrolyzed by enzymes such as salivary and pancreatic alpha-amylase and intestinal alpha-glucosidases to release glucose for absorption into the bloodstream [StatPearls]. The rate of this hydrolysis is a key factor in postprandial glycemic control, making the process a significant focus in the management of metabolic diseases like Type 2 diabetes [PubMed]. While the bonds themselves are substrates rather than therapeutic protein targets, they are the functional site of action for drugs like acarbose and miglitol, which inhibit the enzymes responsible for their cleavage [Mayo Clinic]. By slowing the breakdown of these bonds, these medications reduce the magnitude of blood glucose spikes after meals [Journal of Diabetes Investigation]. However, the inhibition of starch digestion can lead to the fermentation of undigested carbohydrates in the colon, resulting in side effects such as flatulence and osmotic diarrhea [NCBI].

Other names
Dietary starchα-1,4-glycosidic bondAmyloseAmylopectinAlpha-1,4-glucanα-1,4-linkage
02

Mechanism of action

Competitive inhibition of alpha-amylase and alpha-glucosidase enzymes to prevent the hydrolysis of alpha-1,4-glycosidic bonds.

03

Biological functions

Energy storageDietary energy sourceSubstrate for enzymatic hydrolysisOther
04

Disease associations

Diabetes mellitus type 2ObesityPostprandial hyperglycemiaCardiovascular diseaseOther
05

Safety considerations

FlatulenceDiarrheaAbdominal painCarbohydrate malabsorptionHypoglycemia (when combined with other antidiabetic agents)
06

Interacting drugs

Acarbose

2 more in the full profile.

07

Biomarkers

Postprandial blood glucose levelsGlycated hemoglobin (HbA1c)Hydrogen breath test (for carbohydrate malabsorption)

Beyond the preview

Go deeper on Alpha-1,4-glycosidic bond.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1,4-glycosidic bond.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call